Carbo Ceramics Inc. (CRR) Drops 8.58% on January 06

Equities Staff |

Carbo Ceramics Inc. (CRR) was one of the Russell 2000's biggest losers for Wednesday January 06 as the stock slid 8.58% to $15.93, a loss of $-1.495 per share. Starting at an opening price of $16.62 a share, the stock traded between $15.65 and $16.68 over the course of the trading day. Volume was 320,083 shares over 2,939 trades, against an average daily volume of 568,770 shares and a total float of 23.29 million.

The losses send Carbo Ceramics Inc. down to a market cap of $370.83 million. In the last year, Carbo Ceramics Inc. has traded between $47.04 and $14.77, and its 50-day SMA is currently $17.60 and 200-day SMA is $29.02.

Carbo Ceramics Inc is engaged in the supply of ceramic proppant. It provides fracture simulation software, fracture design, engineering and consulting services and a broad range of technologies for spill prevention, containment and countermeasures.

Carbo Ceramics Inc. is based out of Houston, TX and has some 1,048 employees. Its CEO is Gary A. Kolstad.

For a complete fundamental analysis analysis of Carbo Ceramics Inc., check out Equities.com’s Stock Valuation Analysis report for CRR. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Veritas Pharma Inc.

Veritas Pharma Inc, formerly Seashore Organic Medicine Inc is an emerging producer and distributor of medical marijuana.

Private Markets

Wealthfront

Wealthfront is an automated investment service that serves as an alternative to traditional financial advisory services. The company manages a diversified, continually rebalanced portfolio of index funds on their clients’…

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…